Abstract Prolonged mechanical ventilation (MV) is associated with both short-term morbidities and neurodevelopmental impairment. The ability of clinicians to accurately predict successful extubation is limited. Extubation failure may also be associated with significant shortand long-term morbidities. There are limited conflicting data from a few studies evaluating the role of pulmonary function and autonomic nervous system function in predicting the success of elective extubations. Also, the methodology used in some studies may not be easily applied in the clinical setting. There is a need to identify good objective criteria for predicting successful extubation, which may help reduce the duration of MV as well as the incidence of failed extubation.
Introduction
Many extreme preterm infants (gestational age B28 weeks) are unable to sustain adequate oxygenation and ventilation without the support of mechanical ventilation (MV). In a large multicenter cohort study (n = 5,364), 89 % of the extremely low birth weight (ELBW) infants required MV during the first day of life [1] . The coexistence of lung immaturity, weak respiratory drive and surfactant deficiency often contributes to this dependency on MV during the first days of life. Unfortunately, the need for MV is associated with increased mortality and morbidities such as ventilatorassociated pneumonia, pneumothorax and bronchopulmonary dysplasia [2, 3] . Furthermore, each additional week of MV is associated with a significant increase in neurodevelopmental impairment [1] . Thus, clinicians have considered extubation of preterm infants as early as possible a goal of care.
The disconnection of a patient from MV is a complex and continuous process that involves active weaning of the ventilatory settings, evaluation of extubation readiness, and provision of adequate supervision and non-invasive support following disconnection. There are three important shortfalls in our understanding of this process in this vulnerable group. First, the methods of weaning from the ventilator and proceeding toward extubation have been variable and inconsistent across neonatal units. Second, our ability to accurately predict which infants are ready for extubation has been suboptimal. Finally, the ideal method of noninvasive support is still under investigation. For these reasons, extreme preterm infants have the highest rates of extubation failure, with up to 50 % of ELBW infants failing extubation in some centers [4] [5] [6] .
Extubation failure is a significant clinical problem. The prevalence of extubation failure is quite difficult to determine since the criteria used for re-intubation and definitions of failure are diverse. Common reasons for reintubation include severe or frequent apneas, hypoxemia, increased work of breathing and significant respiratory acidosis [7] . The majority of recent studies have defined extubation failure as the need for re-intubation within 72 h of extubation, but this definition is empirical and lacks strong evidence to support it [6, 8, 9] .
Extubation failure has been independently associated with increased mortality rates, longer length of hospital stay, and more days on oxygen and ventilatory support [9] [10] [11] . In the short-term, endotracheal reintubation is not an easy and benign process. The proficiency in intubation of premature neonates has declined over the last years, with recent studies reporting successful rates between 60 and 73 %, with a long time needed for intubation [12, 13] . Endotracheal intubation may further be associated with discomfort to the patient, malposition of the tube, trauma to the airway and hemodynamic instability [12, [14] [15] [16] [17] . It has even been associated with alterations in brain function, as monitored by EEG [18] .
Thus, the current literature clearly supports that both prolonged ventilation and premature unsuccessful extubation followed by reintubation are associated with poor outcomes. Therefore, determining the optimal time and best strategy for successful weaning and extubation of ventilated premature infants is crucial to reduce unwarranted complications.
When to Extubate
Neonatologists should start to consider weaning the levels of ventilatory support as soon as the extreme preterm infant is intubated. It is critical that a proactive weaning process is in place and followed. This will allow for the provision of minimal necessary support, while reducing lung injury. Preterm infants should then be considered for extubation when at minimal ventilatory settings and deemed at the highest chance of a successful attempt. Unfortunately, the ability to determine this has proven to be very difficult. In the absence of specific protocols, weaning from MV has been highly dependent on the physician's expertise and past experiences. Furthermore, the rates of weaning ventilatory parameters and the decision to extubate is still based on clinical evaluation, blood gases, oxygen needs and level of ventilatory support [8] . In the absence of objective, evidence-based criteria, there is still no consensus on the ventilator settings at which a preterm infant should be considered for extubation with a high likelihood of success.
Use of Weaning Protocols
There is salient evidence that ventilation protocols improve outcomes, reduce costs, and decrease the duration of MV and length of stay in adult intensive care units [19] [20] [21] . The Cochrane systematic review of three trials in critically ill pediatric patients suggested that protocolized weaning from the ventilator reduced the duration of MV but had no significant effects on length of stay in the hospital or pediatric intensive care unit, mortality or adverse events [22] . In contrast, there is a paucity of data on the role of weaning protocols in the neonatal population. A single observational study from Canada noted that implementation of a protocol for weaning and extubation of premature infants resulted in improved outcomes, earlier extubation and an increase in the success of extubation [23 • ].
Pre-extubation Ventilation Strategies
With the rapid advancement of technology, neonatologists are faced with the difficult task of choosing the best ventilator mode for their patients. Popular modes of ventilation include assist control (A/C), synchronized intermittent mandatory ventilation (SIMV) and high-frequency oscillatory ventilation (HFOV). When compared with SIMV, A/C appears to provide more homogeneous tidal volumes, less work of breathing and more rapid weaning from MV [24, 25] . However, the combination of SIMV with pressure support (PS) circumvents the resistance of the endotracheal tube and may potentially be comparable to A/C in weaning toward extubation [26] . Another attractive ventilation strategy has been the use of volume-controlled ventilation, as opposed to pressure-limited ventilation, in weaning preterm infants. In this mode, weaning occurs automatically as the patient's lung compliance improves. Volumetargeted ventilation reduces the risk of barotrauma and ventilator-induced lung injury, and it has been associated with lower rates of death, BPD and shorter durations of MV [27] . Direct extubation of preterm infants from HFOV is also practiced in some centers, although no study has looked at benefits incurred from this approach. In a recent review article, Sant'Anna and Keszler [7] proposed guidelines of ventilatory settings from which preterm infants (younger than 2 weeks) may be extubated, according to the ventilation mode used.
Permissive Hypercapnia
In conjunction with volume-targeted ventilation, permissive hypercapnia is a strategy that may facilitate weaning from MV and reduce ventilator-induced lung injury. Various PaCO 2 targets have been used in studies, although generally they are limited by a pH of at least 7.20-7.25. Preterm infants exposed to permissive hypercapnia for 10 days or longer have shown improved respiratory drive, a reduction in number of days on MV, and a trend toward reduction of BPD or death [28] . This effect has not been observed when the intervention was done in the first 4 postnatal days. Moreover, the safe limits of PaCO 2 in the first few days of life may be very different than during the chronic phase of BPD. For this reason, more research is necessary to elucidate the optimal target CO 2 levels and durations for optimizing the strategy of permissive hypercapnia. In the meantime, it appears suitable to target PaCO 2 levels of 50-60 while maintaining a pH over 7.20.
Oxygen Saturation Ranges
Oxygen supplementation is very commonly provided to extremely preterm infants during MV. Despite the recently heightened interest in the subject, our current knowledge of the optimal range of oxygen saturation (SpO 2 ) in this vulnerable population remains limited. From the current available literature, it appears that both very high (95-98 %) and very low (83-87 %) SpO 2 ranges may be harmful to the preterm infant. In the benefit of oxygen saturation targeting (BOOST) trial, infants assigned to the high saturation group (95-98 %) had higher O 2 dependency at 36 weeks post-conceptual age and higher home O 2 therapy compared to their peers in the 91-94 % SpO 2 range [29] . There were no conferred benefits from highsaturation on growth or neurodevelopmental measures. Similar results were obtained in the supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP) trial, whereby infants exposed to the higher saturation targets (SpO 2 96-99 %) had longer hospitalizations as well as prolonged oxygen and ventilator dependence [30] . In the surfactant, positive pressure and pulse oximetry randomized (SUPPORT) trial, infants in the lower SpO 2 range (85-89 %) had significantly lower rates of severe retinopathy among survivors. However, there was also a higher mortality rate overall, which raised serious concerns about the safety of this practice [31] . The more recent BOOST II Trial (UK, Australia, New Zealand) also showed increased mortality in the 85-89 % saturation group during an interim safety analysis, which prompted earlier termination of the study [32] . Interestingly, the latest Canadian oxygen trial (COT) did not report any differences in mortality between high-and low-saturation groups [33] . A meta-analysis is currently underway, by the Neonatal Oxygenation Prospective Meta-analysis Collaboration, to analyze individual patient data from all of the aforementioned trials [34] . In the meantime, it appears prudent to keep SpO 2 between 91 and 95 % in extremely preterm infants until more data are available.
Postnatal Corticosteroids
Extremely preterm infants who are on prolonged MV (beyond 7-14 days) are at high risk of developing BPD.
Systemic corticosteroids can be very effective in the process of weaning from MV and in the treatment of BPD. However, their routine use has fallen out of favor since recognition of their potential harms on neurodevelopmental outcomes [35] . These harms were mainly found in studies where corticosteroids were given in the first week of life, at very high doses and for protracted periods. In fact, the American Academy of Pediatrics Committee on Fetus and Newborn published a policy statement in 2010 stating that low-dose dexamethasone or low-dose hydrocortisone may facilitate extubation and decrease the incidence of BPD without affecting long-term neurodevelopmental outcomes [36, 37] . Notwithstanding, their routine is still not recommended. For patients with a history of airway edema due to multiple intubations, traumatic intubations or prolonged intubations, a short course of dexamethasone in the periextubation period may facilitate successful extubation. For this reason, clinicians should balance the risks of BPD with the potential adverse effects of postnatal steroids on an individual basis, in conjunction with the infant's parents. According to the current literature, it is preferable to administer a short course of dexamethasone at a starting dose of approximately 0.15 mg/kg/day or hydrocortisone at a starting dose of approximately 5 mg/kg/day.
Predictors of Successful Extubation
Once the preterm infant has achieved ventilatory settings when extubation seems to be a reasonable next step, physicians should evaluate whether the patient is 'ready' or not for extubation. This is a very important phase of this whole process since some patients can be easily weaned to low settings but are not yet prepared to cope with respiration without invasive support. The following section will review the role of clinical factors, pulmonary function tests, spontaneous breathing trials (SBT) and autonomic nervous system function evaluation in assessing extubation readiness in extremely preterm infants.
Clinical Factors
Several epidemiological studies have tried to identify the risk factors associated with extubation failure in preterm infants. Those include low gestational age (\26 weeks), prolonged ventilation ([10-14 days), low pH and extubation from high ventilatory settings (e.g., high mean airway pressure and high FiO 2 ) [6, 7, 9] . Infants with a history of previous extubation failure or multiple intubation attempts are also predisposed to fail extubation again. In addition, the presence of other morbidities, such as residual lung disease (e.g., bronchopulmonary dysplasia) or a hemodynamically significant patent ductus arteriosus (PDA) can increase the likelihood of extubation failure [7] . Recent attempts have been made to create automated prediction models, using machine learning approaches to aid clinicians in making an objective decision about optimal extubation time [38, 39] . These methods, although very attractive, require further prospective clinical validation.
Pulmonary Function Tests
Data on pulmonary function testing prior to extubation of preterm infants are limited and conflicting [8, 9, [40] [41] [42] [43] [44] [45] [46] . Some of the variables that have been investigated include tidal volume, minute ventilation (MV), functional residual capacity (FRC), compliance and airway resistance. Most studies have a small sample size, comprise a wide range of gestational ages and often fail to control for confounders such as infection, lung disease and PDA. Moreover, they were done at a time when antenatal corticosteroids, surfactant and gentler ventilation strategies were still not part of routine practice. For instance, Szymankiewicz and Balsan [41, 42] noted that higher lung compliance and lower airway resistance measured prior to extubation of very low birth weight infants were predictive of successful extubation. However, these studies did not control for surfactant, antenatal steroids or caffeine, and most infants did not receive continuous positive airway pressure (CPAP) consistently after extubation. In contrast, VenessMeeham and Chawla [9, 40] showed that lung compliance was a poor predictor of successful extubation in preterm infants with RDS. Other studies, more reflective of current practices, have shown some merit to measurements of MV as well as respiratory and diaphragmatic pressure-time indices to assess respiratory muscle strength and diaphragmatic efficiency, respectively [44] [45] [46] . Nonetheless, these tests have only been evaluated in a small sample population and would need to be prospectively reproduced on a much larger scale.
Spontaneous Breathing Trials
SBTs have been validated and extensively used in adult and pediatric patients as a means of predicting successful extubation [47] [48] [49] . In premature infants, though, data to justify their use are insufficient. A meta-analysis on SBT concluded that preterm infants should be extubated directly without a trial of SBT [50] . However, the meta-analysis included old studies ([20 years old) in which ventilation strategies were very different. Furthermore, the duration of spontaneous breathing was long (ranging from 6 to 24 h) and the pressures used during endotracheal CPAP were low (2-4 cm H 2 O) [51] [52] [53] .
A number of more recent studies have redefined the role of SBTs. Gillespie and colleagues conducted a small randomized controlled trial (n = 42) assessing the performance of a spontaneous MV test in neonates with respiratory distress syndrome. Infants were placed on ETT-CPAP (3-4 cm H 2 O) for 10 min while spontaneous MV was measured. The MV test was considered successful when the ratio of spontaneous to mechanical MV exceeded 50 %. Infants evaluated by the MV test were extubated in a significantly shorter period of time (mean of 8 h) compared to those evaluated clinically (mean of 36 h), with a positive predictive value of 76 % [44] . Vento and colleagues enrolled 41 ELBW infants and performed a 2-h endotracheal CPAP trial. They noted that the mean value of spontaneous expiratory minute volume was significantly lower in the failure group than in the successful group [45] . Kamlin et al. performed a 3-min endotracheal CPAP trial in premature infants (birth weight \1,250 g, n = 50) prior to extubation. Failure of the test was defined as a desaturation or bradycardia for longer than 15 s despite a 15 % increment in FiO 2 . This test showed great sensitivity, with positive and negative predictive values of 93 and 89 %, respectively [54] . Finally, Chawla et al. performed a 5-min SBT in 49 premature neonates (\32 weeks) who were less than 3 weeks of age. The SBT was classified as failed if the patient met any one of the following: significant bradycardia (heart rate \100 beats/min for more than 10 s), oxygen desaturation (\85 % for [15 s) or significant bradycardia requiring intervention. The test showed excellent sensitivity and positive predictive values (88 %), but the specificity and negative predictive values were low [9] .
In a prospective observational cohort study among 122 ventilated adults, three clinical variables predicted reintubation despite a successful SBT: moderate to copious endotracheal secretions (p = 0.001), Glasgow Coma Scale score B10 (p = 0.004), and hypercapnia (PaCO 2 ) C44 mm Hg during the spontaneous breathing trial (p = 0.001) [55] .
The latest studies clearly show the promise of SBTs, which can be easily performed at the bedside, in predicting extubation readiness of preterm infants. But much debate still remains around the optimal duration of the SBT, the CPAP level employed and the criteria to define failure of the test. A larger randomized trial would be warranted to better answer these questions.
Autonomic Nervous System Function
Variations in heart rate and respiratory rate are well known to be influenced by the autonomic nervous system (ANS). In fact, integrity of the cardiovascular system depends on the right balance between sympathetic and parasympathetic tones [56] . Autonomic dysfunction, as characterized by reduced heart rate variability (HRV), has been linked to increased mortality and cardiovascular disease in adult individuals [57] . Respiratory variability (RV), on the other hand, is reduced in conditions of hypoxia, hypercapnia and inspiratory mechanical loading (elastic or resistive) [58] [59] [60] [61] . The adult literature has consistently demonstrated reduced HRV and RV in adult patients who fail weaning from MV [62, 63] .
The role of HRV and RV in predicting disease in newborn infants is not as well understood. It has however gained popularity over the past years, especially with the latest evidence that loss of HRV precedes the clinical presentation of late-onset neonatal sepsis [64] . With regards to prediction of extubation readiness, a recent small prospective observational study of 56 preterm infants (birth weight B1,250 g) showed that HRV was significantly decreased in those who failed extubation [65 •• ] . Another study evaluated the performance of SBT and RV for prediction of extubation readiness. The combined effect of both parameters predicted successful extubation more accurately than either parameter alone [66
Measurement of ANS function appears to be of great future promise for predicting extubation readiness in preterm infants. Ideally, the technology should be easy to use by clinicians at the bedside, without arduous analysis. The development of automated machine learning methods to facilitate interpretation of the results would be helpful.
How to Extubate
Once an infant is deemed ready for extubation, a number of steps need to be followed methodically to ensure a successful transition. The process of extubation takes time, meticulous planning and requires the full collaboration of all team members caring for the infant (including clinicians, nurses and respiratory therapists). The procedure itself should be done in a controlled environment, in the presence of personnel skilled in respiratory stabilization and intubation (if needed). The following section will review some of the evidence-based strategies to improve extubation success in preterm infants (summary in Table 1 ).
Use of Caffeine Prior to Extubation
The benefits of caffeine for extremely preterm infants have been suggested in several small single-center studies and confirmed by a large multi-center trial conducted in 2006 (CAP trial) [67] . This randomized controlled trial showed that infants assigned to the caffeine group had less BPD, a shorter duration on supplemental oxygen and were intubated for almost 1 week less. A secondary, post hoc subgroup analysis showed that early administration of caffeine (before 3 days of life) could further reduce the time on MV [68 • ] . From these studies, we conclude that caffeine is beneficial and should be part of the regimen when preparing an infant for extubation. It appears reasonable to give it within at least 24 h from the projected time of extubation. However, although tempting, the routine administration of caffeine immediately after birth (or in the first few hours after birth) has not been investigated.
Post-extubation Ventilation Strategies
Following extubation, premature infants still have insufficient respiratory drive and muscle strength to maintain FRC independently. For this reason, a distending pressure is necessary to reduce the risk of post-extubation atelectasis. This pressure should be applied immediately after the removal of the endotracheal tube and may be provided in the form of CPAP or nasal intermittent positive pressure ventilation (NIPPV) using short, bi-nasal prongs or nasal masks. Among 1,009 preterm infants randomly assigned to either NIPPV or nasal CPAP-at the time of the first use of noninvasive respiratory support during the first 28 days of life-rates of death or BPD and reintubation after randomization were comparable [69
The use of heated humidified high-flow nasal cannula (HHHFNC) post-extubation has gained popularity over the past few years. Two RCTs have evaluated the use of HHHFNC in preventing extubation failure compared to nasal CPAP in preterm infants and have showed HHHFNC to be as effective and safe as CPAP [70 • , 71 •• ]. However, only one of those studies looked specifically at the extremely preterm population (B28 weeks gestation). For infants \26 weeks of gestation at birth, no conclusion could be inferred [ 
Treatment of Postextubation Stridor
Postextubation stridor is a relatively common occurrence that could increase the risk of extubation failure among [72] . However, in one of the studies targeting high-risk infants only, the incidence of stridor was significantly reduced when multiple doses of steroids were given around the time of extubation [73] . Therefore, it appears reasonable to reserve this therapy for high-risk infants only, until more evidence is available.
Tracheostomy
There is a paucity of literature on the indications and timing of tracheostomy in preterm infants who fail multiple extubation attempts or cannot be weaned from MV. The overall rate of neonatal tracheostomy ranges between 0.55 and 2.7 %, with even higher rates in the extreme low birth weight population [74] . In practice, these infants are submitted to a tracheostomy if they remain ventilatordependent by a corrected gestational age near term (± month of life). A tracheostomy is generally performed in the hopes of effectively decreasing the need for invasive respiratory support, improving oral-motor skills and childhood lung function, improving neurodevelopmental outcomes or simply expediting discharge home. This high variability in desired objectives of tracheostomy makes it very difficult to propose any specific recommendations about its use.
Conclusion
Determining when and how extremely preterm infants can be extubated continues to be challenging. Development of clinical guidelines based on clinical characteristics of the patient along with combinations of SBT, pulmonary function tests and autonomic nervous system function will help clinicians better determine the optimal timing for elective extubation. Moreover, the development of protocols for weaning and extubating preterm infants, as well as post-extubation management and adjunctive therapies may prove to be beneficial in achieving successful elective extubations.
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